AI, family genetics and fly experiments strengthen a BRSK1 disease clue
An AI-prioritized genetic clue, evidence from seven families and fruit-fly experiments helped researchers investigate BRSK1 variants associated with a rare developmental disorder.
Texas Children’s September 28 report combines an AI-prioritized BRSK1 clue with evidence from ten affected people in seven families and fruit-fly experiments.
AI-MARRVEL highlighted the variant after an initial genetic analysis was unrevealing.
Normal human BRSK1 largely rescued the flies' neurological defects; affected individuals' variants produced only partial rescue. The account reports no numerical rescue rate. That adds functional evidence to a genetic association. It does not show that an AI diagnosis is sufficient, or establish a treatment.
For families facing an unexplained condition, the practical connection is the Texome Project, the Houston research programme involved in this work. Its patient page describes eligibility for underserved people with a suspected rare disease who cannot afford sequencing, including people without insurance or with public insurance. It offers study-related testing and consultations without charge and describes five visits over two years. Contact the team to confirm eligibility and current enrolment; participation does not guarantee an explanatory result.
We checked the institutional account and programme details. The publisher's article endpoints were inaccessible, so the full methods and variant-level analyses were not independently reviewed. September 28 is the date of the institutional announcement; we could not establish the paper's exact first-online date.
Take it further
Check Texome eligibility Houston research programme for underserved people with suspected rare disease and financial barriers to sequencing. Confirm eligibility and current enrolment with the team; no deadline is published and a diagnosis is not guaranteed.
Sources & details 4 sources
Discuss in your voice app
Take the reporting, visual explanations and original sources into a conversation. Copy the brief, paste it into your preferred assistant, then start its voice mode.
Paste the brief into your voice app to discuss this reporting.Revised 4 October 2026. Reporting and visuals refined. Original source dates and prior checks retained.
Reporting sources
- Texas Children's — original research announcement
Dated September 28. AI-MARRVEL role, ten individuals/seven families and fly experiments checked in the institutional report.
- American Journal of Human Genetics — cited study
DOI and title corroborated by the investigators' publication list and Crossref. Publisher abstract/full-text endpoints were inaccessible; methods not reviewed.
- Bellen laboratory — publication record
The investigators list the BRSK1 study in the American Journal of Human Genetics as in press. This corroborates identity, not independent results.
- Texome Project — patient eligibility and participation
Eligibility, no-cost study visits/testing, five visits over two years and possibility of an uninformative result checked September 29. No enrolment deadline published.
Images & figures
An AI-prioritised clue, ten affected people in seven families, and fly experiments support the BRSK1 investigation. Normal human BRSK1 largely rescued neurological defects; patient variants produced partial rescue. These are qualitative descriptions, with no rescue percentages shown. Publisher methods were inaccessible, and no treatment is established.